Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
International Journal of Surgery (London, England)
|
June 24, 2025
Non-invasive prediction of NSCLC immunotherapy efficacy and tumor microenvironment through unsupervised machine learning-driven CT Radiomic subtypes: a multi-cohort study
Yusheng Guo, Bingxin Gong, Yi Li, et al.
Frontiers in Immunology
|
May 3, 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors
Jie Lou, Bingxin Gong, Yi Li, et al.
NPJ Precision Oncology
|
March 28, 2026
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study
Yusheng Guo, Bingxin Gong, Jie Lou, et al.
Translational Lung Cancer Research
|
June 19, 2025
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
Weiwei Liu, Yusheng Guo, Peng Mo, et al.
BMC Medical Imaging
|
July 2, 2025
Development and validation of AI-based automatic segmentation and measurement of thymus on chest CT scans
Yusheng Guo, Bingxin Gong, Guowei Jiang, et al.
Translational Lung Cancer Research
|
August 9, 2024
Association between thymus density loss and efficacy in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Yi Li, Bingxin Gong, Jie Lou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 20, 2025
Radiomics-Based Unsupervised Clustering Identifies Subtypes Associated With Prognosis and Immune Microenvironment in Clear Cell Renal Cell Carcinoma: A Multicenter Study
Yusheng Guo, Bingxin Gong, Yi Li, et al.
Medcomm
|
September 24, 2025
A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective Study
Bingxin Gong, Yusheng Guo, Qi Wan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
International Journal of Surgery (London, England)
|
June 24, 2025
Non-invasive prediction of NSCLC immunotherapy efficacy and tumor microenvironment through unsupervised machine learning-driven CT Radiomic subtypes: a multi-cohort study
Yusheng Guo, Bingxin Gong, Yi Li, et al.
Frontiers in Immunology
|
May 3, 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors
Jie Lou, Bingxin Gong, Yi Li, et al.
NPJ Precision Oncology
|
March 28, 2026
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study
Yusheng Guo, Bingxin Gong, Jie Lou, et al.
Translational Lung Cancer Research
|
June 19, 2025
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
Weiwei Liu, Yusheng Guo, Peng Mo, et al.
BMC Medical Imaging
|
July 2, 2025
Development and validation of AI-based automatic segmentation and measurement of thymus on chest CT scans
Yusheng Guo, Bingxin Gong, Guowei Jiang, et al.
Translational Lung Cancer Research
|
August 9, 2024
Association between thymus density loss and efficacy in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Yi Li, Bingxin Gong, Jie Lou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 20, 2025
Radiomics-Based Unsupervised Clustering Identifies Subtypes Associated With Prognosis and Immune Microenvironment in Clear Cell Renal Cell Carcinoma: A Multicenter Study
Yusheng Guo, Bingxin Gong, Yi Li, et al.
Medcomm
|
September 24, 2025
A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective Study
Bingxin Gong, Yusheng Guo, Qi Wan, et al.
Page
of 3